Item 5.07 Submission of Matters to a Vote of Security Holders.





On August 3, 2020, Menlo Therapeutics Inc. (the "Company") held its 2020 Annual
Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, the
Company's stockholders voted on three proposals, each of which is described in
more detail in the Company's definitive proxy statement filed with the
Securities and Exchange Commission on June 22, 2020. Only stockholders of record
as of the close of business on June 10, 2020, the record date for the Annual
Meeting, were entitled to vote at the Annual Meeting. As of the record date,
167,622,305 shares of the Company's common stock were outstanding and entitled
to vote at the Annual Meeting. The following is a summary of the matters voted
on at the Annual Meeting, including the approval percentage for each proposal,
represented as a percentage of total votes cast for each such proposal, and for
Proposal 3, the percentage of total shares outstanding that voted in favor

of
the proposal.



Proposal 1. The stockholders elected the following two directors to the
Company's Board of Directors (the "Board"), to hold office until the 2023 annual
meeting of stockholders or until their respective successors are elected. The
voting results were as follows:



                                             Votes
      Nominee           Votes For           Withheld         Broker Non-Votes       Approval Percentage
Sharon Barbari            84,804,720          1,130,463             39,045,741                        99 %
Rex Bright                84,864,133          1,071,050             39,045,741                        99 %

Proposal 2. The stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2020. The voting results were as follows:





   Votes For         Votes Against         Abstentions           Broker Non-Votes         Approval Percentage
122,493,089                1,315,205            1,172,630                          0                        99 %




Proposal 3. The stockholders approved a proposal to adopt an amendment to the
company's Amended and Restated Certificate of Incorporation to effect (a) a
reverse stock split of the company's outstanding shares of common stock, at a
reverse stock split ratio ranging from 1-for-2 to 1-for-7 shares, which may be
determined by the Board at a later date, and (b) a reduction in the number of
authorized shares of the Company's common stock by a corresponding ratio
(collectively, the "reverse stock split proposal"). As of the date hereof, the
Board has not made any determination on the filing of such amendment. The voting
results were as follows:



                                                                                    Percentage of
                                                                                        Shares           Approval

Votes For Votes Against Abstentions Broker Non-Votes Outstanding Percentage 110,553,351

               13,624,684           802,889                       0                   66 %           89 %

© Edgar Online, source Glimpses